Aspen Technology to Present at the William Blair Growth Stock Conference
Get Alerts AZPN Hot Sheet
Join SI Premium – FREE
BEDFORD, Mass.--(BUSINESS WIRE)-- Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in asset optimization software, today announced that Antonio Pietri, President and Chief Executive Officer, and Karl Johnsen, Chief Financial Officer, will present at the virtual William Blair Growth Stock Conference. The presentation is scheduled for Wednesday, June 10, 2020 at 4:40 p.m. CT.
The presentation will be webcast live and available for a limited time on the Investor Relations section of the company’s website at http://ir.aspentech.com/.
About AspenTech
Aspen Technology (AspenTech) is a global leader in asset optimization software. Its solutions address complex, industrial environments where it is critical to optimize the asset design, operation and maintenance lifecycle. AspenTech uniquely combines decades of process modeling expertise with artificial intelligence. Its purpose-built software platform automates knowledge work and builds sustainable competitive advantage by delivering high returns over the entire asset lifecycle. As a result, companies in capital-intensive industries can maximize uptime and push the limits of performance, running their assets safer, greener, longer and faster. Visit AspenTech.com to find out more.
© 2020 Aspen Technology, Inc. AspenTech, aspenONE, and the Aspen leaf logo are trademarks of Aspen Technology, Inc. All rights reserved. All other trademarks are property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005758/en/
Media:
Lucy Millington
AspenTech
+1 781-221-6419
[email protected]
Investor:
Brian Denyeau
ICR
+1 646-277-1251
[email protected]
Source: Aspen Technology, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best’s Market Segment Report: Asia-Pacific Reinsurers Show Resilience Amid Evolving Market Landscapes
- Consortium launches cross-regional pilot on post-quantum security with participation from banks and regulatory stakeholders
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share